{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T07:09:04Z","timestamp":1780816144998,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.clim.2017.09.012","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T16:54:32Z","timestamp":1505408072000},"page":"300-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome"],"prefix":"10.1016","volume":"183","author":[{"given":"Adrianos","family":"Nezos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilir","family":"Cinoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clio P.","family":"Mavragani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haralampos M.","family":"Moutsopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2017.09.012_bb0005","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1172\/JCI116713","article-title":"The cytokeratin filament-aggregating protein filaggrin is the target of the so-called \u201cantikeratin antibodies\u201d autoantibodies specific for rheumatoid arthritis","volume":"92","author":"Simon","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2017.09.012_bb0010","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/annrheumdis-2012-201484","article-title":"Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein\/peptide antibody fine specificity profile","volume":"72","author":"Lundberg","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.09.012_bb0015","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/annrheumdis-2012-202701","article-title":"The autoantibody repertoire in periodontitis: a role in the induction of autoimmunity to citrullinated proteins in rheumatoid arthritis?","volume":"73","author":"de Pablo","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.09.012_bb0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cei.12145","article-title":"Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis","volume":"174","author":"Goules","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2017.09.012_bb0025","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng.480","article-title":"Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis","volume":"41","author":"Mahdi","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2017.09.012_bb0030","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/ard.2010.138909","article-title":"Antibodies to citrullinated alpha-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis","volume":"70","author":"Fisher","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.09.012_bb0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaut.2012.03.001","article-title":"Subgroups of Sjogren syndrome patients according to serological profiles","volume":"39","author":"Bournia","year":"2012","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2017.09.012_bb0040","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1007\/s00296-011-2274-3","article-title":"The clinical significance of anti-cyclic citrullinated peptide antibody in primary Sjogren syndrome","volume":"32","author":"Kim","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.clim.2017.09.012_bb0045","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10067-016-3175-3","article-title":"Polyarthritis in primary Sjogren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up","volume":"35","author":"ter Borg","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2017.09.012_bb0050","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/ar2420","article-title":"Anti-cyclic citrullinated peptide antibodies in primary Sjogren syndrome may be associated with non-erosive synovitis","volume":"10","author":"Atzeni","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2017.09.012_bb0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3899\/jrheum.080193","article-title":"Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies","volume":"36","author":"Iwamoto","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2017.09.012_bb0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/ard.2003.019794","article-title":"Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjogren's syndrome","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2017.09.012_bb0065","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Group on classification criteria for Sjogren's, classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European consensus group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann. Rheum. Dis."},{"issue":"2010","key":"10.1016\/j.clim.2017.09.012_bb0070","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2017.09.012_bb0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13075-015-0613-6","article-title":"Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren's syndrome: prevalence, clinical and laboratory associations","volume":"17","author":"Gravani","year":"2015","journal-title":"Arthritis Res. & Ther."},{"key":"10.1016\/j.clim.2017.09.012_bb0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4049\/jimmunol.1102073","article-title":"Alpha-enolase expressed on the surfaces of monocytes and macrophages induces robust synovial inflammation in rheumatoid arthritis","volume":"189","author":"Bae","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2017.09.012_bb0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2796.1991.tb00429.x","article-title":"Nephrocalcinosis in Sjogren's syndrome: a late sequela of renal tubular acidosis","volume":"230","author":"Moutsopoulos","year":"1991","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.clim.2017.09.012_bb0090","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00005792-200007000-00005","article-title":"Clinically significant and biopsy-documented renal involvement in primary Sjogren syndrome","volume":"79","author":"Goules","year":"2000","journal-title":"Medicine"},{"key":"10.1016\/j.clim.2017.09.012_bb0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.amjmed.2004.07.049","article-title":"Autoantibodies against carbonic anhydrase II are increased in renal tubular acidosis associated with Sjogren syndrome","volume":"118","author":"Takemoto","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.clim.2017.09.012_bb0100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jprot.2013.01.001","article-title":"Cellular adaptive response of distal renal tubular cells to high-oxalate environment highlights surface alpha-enolase as the enhancer of calcium oxalate monohydrate crystal adhesion","volume":"80","author":"Kanlaya","year":"2013","journal-title":"J. Proteome"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661617304382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661617304382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:02:07Z","timestamp":1761494527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661617304382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":20,"alternative-id":["S1521661617304382"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2017.09.012","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2017.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}